Showing results (1151-1160 of 1,650) with videos related to
Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|July 31, 2025
Longitudinal Descriptive Analysis of Dynamic Changes in Safety Concerns in Japanese Risk Management Plans for Medicinal Products Over 8 Years After ApprovalChieko Ishiguro, Mahiro Sazawa, Takahiro NonakaTherapeutic Innovation & Regulatory Science|August 24, 2021
Seasonal and Secular Periodicities Identified in the Dynamics of US FDA Medical Devices (1976-2020): Portends Intrinsic Industrial Transformation and Independence of Certain CrisesIraj DaizadehTherapeutic Innovation & Regulatory Science|August 11, 2021
Healthy Volunteer Studies in the Development of Anticancer Drugs with Genotoxic FindingsGrace Omes-Smit, Marjolein Garsen, Alex ZwiersTherapeutic Innovation & Regulatory Science|June 10, 2020
Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank MeetingTrevor A Lentz, Lesley H Curtis, Frank W Rockhold, et al.Therapeutic Innovation & Regulatory Science|June 12, 2020
Characteristics on Drug Safety Measures in Japan Stratified by System Organ Classes and Therapeutic Categories in Relation to the Approval DateAyaka Hiramatsu, Hideki Hanaoka, Yoshiaki UyamaTherapeutic Innovation & Regulatory Science|June 7, 2020
The Current Status of European and National Financial Sources for Clinical Research and Their Impact on Paediatric Non-commercial Clinical Trials: A Case Study of the Czech RepublicL Horavova, K Nebeska, L Souckova, et al.Therapeutic Innovation & Regulatory Science|July 21, 2025
Transforming Objective Participatory Patient AdvocacyPat Furlong, Timothy R Franson, Peter J PittsTherapeutic Innovation & Regulatory Science|July 21, 2025
Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBaseMeshael M AlRasheed, Solaiman M AlHawas, Nora N AlOrf, et al.Therapeutic Innovation & Regulatory Science|July 27, 2025
Incorporating Patient Needs and Perspectives in Additional Risk Minimization Measures and Other Pharmacovigilance Deliverables - A Framework and Implementation RoadmapLinda Smeding, Robert Massouh, Farai Moyo, et al.Therapeutic Innovation & Regulatory Science|July 27, 2025
Optimizing Biomedical Health Efficiency: Unlocking the Full Potential of Life Science Innovation Through System DesignGigi Hirsch, Sharon E Phares, Jane Barlow, et al.Pageof 165